脳
鏀惰棌-鍋ュ悍緗戜細(xì)鍛樿闂褰?/h3>
| 緗戦〉鏍囬錛? | |
脳
娉ㄥ唽鍋ュ悍緗戠敤鎴?/h3>
| 鐢?鎴?鍚嶏細(xì) | ||
|---|---|---|
| 鑱?緋?浜猴細(xì) | 鎬?nbsp; 鍒細(xì) | |
| 瀵?nbsp; 鐮侊細(xì) | ||
| 閲嶅瀵嗙爜錛?/th> | ||
| 鐢?shù)瀛愰偖绠卞Q?/th> | ||
| 閭楠岃瘉鐮侊細(xì) | ||
| 鍥哄畾鐢?shù)璇濆Q?/th> | ||
| 浼?nbsp; 鐪燂細(xì) | ||
| 鎵?nbsp; 鏈猴細(xì) | ||
| 鍗曚綅鍚嶇О錛?/th> | ||
| 閫氫俊鍦板潃錛?/th> | ||
| 棣栭夋爮鐩細(xì) | ||
| 鎴戝凡緇忚鐪熼槄璇誨茍鍚屾剰銆婂仴搴風(fēng)綉鏈嶅姟鏉℃銆?/a> | ||
| 紜畾娉ㄥ唽 | ||
鎮(zhèn)ㄧ幇鍦ㄤ綅緗細(xì)鍋ュ悍緗?鍖昏嵂浜т笟 >> 浜т笟緇忔祹 >> 浜т笟璧勮 >> 浼佷笟璧勮 >> 嫻忚浜т笟緇忔祹
涔?jié)娲茶嵂涓殲畣鎶曡?200涓囩編鍏冨湪鏃ユ湰寤鴻CRO鏈嶅姟騫沖彴
浣滆咃細(xì)yuanxc 鏉ユ簮錛氫簰鑱旂綉 鐐瑰嚮鏁幫細(xì)0 鏇存柊鏃墮棿錛?024-2-2 15:26:34
[鍏抽敭瀛梋錛?/font> 涔?jié)娲茶嵂涓?/a> CRO 鎶曡祫
鍋ュ悍緗戣錛?/FONT>
涔?jié)娲茶嵂涓殲畣鎶曡?200涓囩編鍏冨湪鏃ユ湰寤鴻CRO鏈嶅姟騫沖彴
脳
鍋ュ悍緗戞彁紺?/span>
鐩稿叧榪炴帴
The industrial chain effect of macrolide APIs is prominent
浠欑悮鍒惰嵂鎷熷弬鎶曞垱鏂拌嵂浼佷笟紱歸縛鍖昏嵂
榪滃ぇ鍖昏嵂鎶曡祫澶氭櫘娉板尰鑽鎶 鍔犵爜蹇?jī)鑴戣綆＄柧鐥呮不鐤楄禌閬?/a>
鍗冮噾鑽笟鎷?000涓囨姇璧勭斁浣撹嵂鐗╁叏浜т笟閾句紒涓氭柊鍚堟柊
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
The project of Angel Yeast Binzhou Company with an annual output of 40,000 tons of new yeast products (microbial protein) has been completed put into production.
嫻欐睙涔?jié)娲茶嵂涓氣滃崵浠-(鍏ㄦ盁鐑峰熀)-浜岃嫰騫跺櫥鍚╃洂鍙?qiáng)鍏跺埗澶囨栆?guī)硶鈥濊崳鑾封滀腑鍥戒笓鍒╀紭縐濂栤?/a>
Analysis of 70 macrocyclic drugs approved by the FDA
浠欑悮鍒惰嵂鎷熷弬鎶曞垱鏂拌嵂浼佷笟紱歸縛鍖昏嵂
榪滃ぇ鍖昏嵂鎶曡祫澶氭櫘娉板尰鑽鎶 鍔犵爜蹇?jī)鑴戣綆＄柧鐥呮不鐤楄禌閬?/a>
鍗冮噾鑽笟鎷?000涓囨姇璧勭斁浣撹嵂鐗╁叏浜т笟閾句紒涓氭柊鍚堟柊
Reasons for the sales growth of macrolides in Guo Bang Pharmaceutical in the first half of 2023
The project of Angel Yeast Binzhou Company with an annual output of 40,000 tons of new yeast products (microbial protein) has been completed put into production.
嫻欐睙涔?jié)娲茶嵂涓氣滃崵浠-(鍏ㄦ盁鐑峰熀)-浜岃嫰騫跺櫥鍚╃洂鍙?qiáng)鍏跺埗澶囨栆?guī)硶鈥濊崳鑾封滀腑鍥戒笓鍒╀紭縐濂栤?/a>
Analysis of 70 macrocyclic drugs approved by the FDA